West German Centre of Diabetes and Health
Düsseldorf, 40591, Germany
NCT Number: NCT02230501
Formerly, the investigators demonstrated in an uncontrolled proof-of principle study (NCT 01680926) that protein-rich meal replacement (PRMR) was successful in reducing daily insulin demand, HbA1c and weight in type 2 diabetes mellitus (T2DM) patients injecting >100 IE insulin/day. The aim of the present study was to investigate in a randomized-controlled trial if PRMR is also effective in T2DM patients treated with oral antidiabetic medication or insulin.
A second part of the study is an open-label registry for persons with type 2 diabetes, who will perform the lifestyle intervention with the stringent diet regime.
Looking for future studies?
Notify Me25 year–79 year
All sexes
Interventional
Not applicable
Düsseldorf, 40591, Germany
Type 2 diabetes mellitus (T2DM) patients had been randomized into two groups. During the 1st week the intervention group with stringent diet regime replaced 3 main meals by 50 g PRMR (Almased-Vitalkost, Almased Wellness GmbH, Bienenbüttel, Germany) each (=1100 kcal/day). In 2nd-4th week 2 meals were replaced and a protein-rich lunch was allowed. In 5th-12th week only dinner was replaced. The control group with moderate diet regime replaced breakfast and dinner for 4 weeks and then only dinner during the next 8 weeks. Clinical parameters were determined at the study center at baseline, after 4, 8 and 12 weeks. Primary endpoint was reduction of HbA1c, secondary endpoints reduction of weight and antidiabetic medication.
In the second part of the study type 2 diabetes patients are included in an open-label reistry and perform the lifestyle intervention with the stringent diet regime.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For the open-label registry, the only inclusion criterium is type 2 diabetes.
Other names: protein-rich meal replacement (PRMR), i.e Almased-Vitalkost (Almased Wellness GmbH, Bienenbüttel, Germany)
Other names: protein-rich meal replacement (PRMR), i.e Almased-Vitalkost (Almased Wellness GmbH, Bienenbüttel, Germany)
Time frame: 12 weeks
change in hemoglobin A1c
Time frame: 1 year
change in hemoglobin A1c
Time frame: 12 weeks and 1 year
change in body weight
Time frame: 12 weeks and 1 year
change in systolic and diastolic blood pressure
Time frame: 12 weeks and 1 year
change in total cholesterol change in HDL cholesterol change in LDL cholesterol
Time frame: 12 weeks and 1 year
change in fastin g blood glucose
Time frame: 12 weeks and 1 year
change in SF-36 quality of life questionnaire change in ADS-L (German version of the general depression scale)
Time frame: 12 weeks and 1 year
change in FEV (questionnaire for eating manners)
Time frame: 12 weeks and 1 year
change in physical activity questionnaire
Time frame: 12 weeks and 1 year
West German Center of Diabetes and Health
Other
Metabolic Activation With Protein-rich Formula Diet - a Randomized-controlled Trial
Acronym: AVS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05411458
Anxiety Disorders, COVID-19
Izmir, Turkey (Türkiye)
View Trial DetailsNCT00467285
Bone Diseases, Bone Diseases, Metabolic
View Trial DetailsNCT02538848
Diabetes Mellitus, Diabetes Mellitus, Type 2
Perth, Australia
View Trial DetailsNCT06353347
Diabetes Mellitus, Diabetes Mellitus, Type 2
Baotou, China
View Trial Details